NoPrescriptionDrugstore.US: Study Reveals Potential Evolutionary Role For Same-Sex Attraction

Study Reveals Potential Evolutionary Role For Same-Sex Attraction
Male homosexuality doesn't make complete sense from an evolutionary point of view...
Source: mnt.to

FDA, FSIS, CDC Collaborate On Methods To Measure Success Of Food Safety Programs
The U.S. Food and Drug Administration, the Centers for Disease Control and Prevention and the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) will host a joint public workshop on how best to measure progress in reducing foodborne illnesses on March 30, in Washington, D.C...
Source: mnt.to

Hearing Loss In Men Increased By Regular Analgesic Use
In a study published in the March 2010 issue of The American Journal of Medicine, researchers determined that regular use of aspirin, acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) increases the risk of hearing loss in men, particularly in younger men, below age 60. Hearing loss is the most common sensory disorder in the US, afflicting over 36 million people...
Source: mnt.to

Poniard Pharmaceuticals Presents Positive Survival Data From A Phase 2 Clinical Study Of Picoplatin In Metastatic Prostate Cancer
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC)...
Source: mnt.to

Male Breast Reduction Fastest Growing Area Of Cosmetic Surgery In Britain Last Year
The economic situation does not appear to have affected the cosmetic surgery business in Britain: new figures from a not-for-profit organisation show that the number of surgical procedures were 6.7 per cent higher in 2009 than 2008, among which the number of male breast reductions went up by 80 per cent...
Source: mnt.to

Proximity To Physical Activity Resources Found To Benefit Older Men
A new study points to the health benefits of living in neighborhoods with built-in physical activity resources. Researchers conducted a study among community-dwelling men age 65 years or older from the Portland, Ore., metropolitan area...
Source: mnt.to

MicroPhage Seeks FDA Clearance To Market World's First Test Designed To Rapidly Identify Bacterial Infections And Antibiotic Susceptibility
MicroPhage announced that it has submitted human data from a pivotal clinical study of its 'Microphage MRSA/MSSA Blood Culture Test' to support a U.S. Food and Drug Administration (FDA) 510(k) premarket notification process. The first of MicroPhage's instrument-free, rapid tests is based on the Company's patented Bacteriophage Amplification platform technology...
Source: mnt.to

Gynecologic Oncology Group Notifies CTI That Continuation Of GOG-212 Pivotal Trial Of OPAXIO Maintenance Therapy In Ovarian Cancer Is A Priority
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue...
Source: mnt.to

Novo Nordisk Receives FDA Approval For Norditropin® FlexPro® For Growth Hormone Treatment
Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved Norditropin® FlexPro® (somatropin [rDNA origin] injection), a pre-filled injection pen to be used by children and adults with growth hormone disorders. It will be available in the second quarter...
Source: mnt.to

# posted by Network @ 8:22 AM